Indications and choice of antihypertensive drugs (cont'd) : British recommendations
Prescrire International 9(48): 123
2000
ISSN/ISBN: 1167-7422 PMID: 11067726 Document Number: 518775
(1) In the absence of other cardiovascular risk factors, antihypertensive monotherapy should be started in patients with a systolic blood pressure of at least 160 mm Hg or a diastolic pressure of at least 100 mm Hg at repeated measurements.
Document emailed within 1 workday
Related Documents
Skolnik, N.S.; Beck, J.D.; Clark, M. 2000: Combination antihypertensive drugs: recommendations for use American Family Physician 61(10): 3049-3056Koster, M. 1980: Different patterns in essential hypertension and possible choice of antihypertensive drugs Archives Internationales de Pharmacodynamie et de Therapie Suppl: 227-232
Amato Neto, V.; Levi, G.C. 1971: Drugs of choice for the treatment of intestinal parasitic diseases, with indications of the respective proper dosages and side effects Revista Paulista de Medicina 78(1): 43-48
Iurin, O.G. 2007: Indications for initiation of antiretroviral therapy in patients with HIV infection. Choice of first-line drugs and schemes of therapy Terapevticheskii Arkhiv 79(11): 67-69
1992: Complementary testing criteria for veterinary drugs applied in animals for choice meat production. Recommendations by the Drug Advisory Commission of the Royal Dutch Society for Veterinary Medicine Tijdschrift Voor Diergeneeskunde 117(13): 393-399
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
Ell, C.; Domschke, S.; Domschke, W. 1982: Benefit-risk considerations in metamizole treatment. Rational recommendations for indications and contra-indications according to current knowledge Fortschritte der Medizin 100(14): 615-618
Soen, S. 2007: First choice drug for treatment of osteoporosis and the strategic points for choice of drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 325-328
Sandoe, J.A.T.; Barlow, G.; Chambers, J.B.; Gammage, M.; Guleri, A.; Howard, P.; Olson, E.; Perry, J.D.; Prendergast, B.D.; Spry, M.J.; Steeds, R.P.; Tayebjee, M.H.; Watkin, R. 2015: Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE) Journal of antimicrobial chemotherapy 70(2): 325-359
Auer, J.; Berent, R.; Weber, T.; Porodko, M.; Mayr, H.; Maurer, E.; Eber, B. 2001: Pharmacologic interventions in primary prevention: lipid lowering drugs, aspirin, antiobesity drugs, and antihypertensive agents Wiener Medizinische Wochenschrift 151(1-2): 13-17
Souviron Rodríguez, A. 1989: Verapamil: a 1st choice antihypertensive agent Medicina Clinica 93(19): Suppl 3 p.
Grégoire, J.P. 1999: Choice of initial antihypertensive medication and continuation of use Canadian Journal of Cardiology 15 Suppl F: 39f-41f
Jennings, A.M.; Smith, C.; Cole, D.R.; Jennings, C.; Shortland, J.R.; Williams, J.L.; Brown, C.B. 1988: Von Hippel-Lindau disease in a large British family: clinicopathological features and recommendations for screening and follow-up Quarterly Journal of Medicine 66(251): 233-249
Bönner, G. 1999: Fat control--an effective antihypertensive strategy. Special recommendations for therapy of the overweight patient MMW Fortschritte der Medizin 141(46): 34-36
2015: New drugs and indications in 2014. Some advances this year, but many drugs are poorly evaluated, too expensive, or more dangerous than useful Prescrire International 24(159): 107-110
Adasheva, T.V.; Samorukova, E.I.; Zadionchenko, V.S.; Nesterenko, O.I. 2013: What is the optimal choice of antihypertensive therapy based on: the class-specific effects or special properties of a drug? Terapevticheskii Arkhiv 85(9): 102-106
Gregoratos, G. 2005: Indications and recommendations for pacemaker therapy American Family Physician 71(8): 1563-1570
Vorburger, C.; Tuckman, J. 1972: New antihypertensive drugs Schweizerische Medizinische Wochenschrift 102(30): 1033-1039
Thind, G.S. 1978: New antihypertensive drugs Journal of the Kentucky Medical Association 76(4): 163-168
Salvadè, P. 1995: Indications for and choice of coronary stents Giornale Italiano di Cardiologia 25(11): 1495-1497